Physician profile
Shawn Christopher Cable
NPI 1558310151
$5,109.09
in general payments reported to CMS, 2019-2025
40 companies · $617 in 2025
The $617 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,265 · 2020: $444 · 2021: $719 · 2022: $821 · 2023: $298 · 2024: $945 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,814 · Education: $45.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,814.15 |
| Education | $45.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,316.19 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Nevro Corp. | $1,144.77 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $280.37 | 2019-2025 | Relistor |
| Vgi Medical, LLC | $255.11 | 2022 | |
| Forte Bio-Pharma LLC | $216.67 | 2020-2024 | Prolate, Nalocet |
| Stryker Corporation | $172.01 | 2024 | Mild Device Kit |
| Trevena, INC. | $162.77 | 2022-2023 | Olinvyk |
| Pacira Therapeutics, INC. | $153.45 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $144.44 | 2019-2022 | |
| Biotronik Nro, INC. | $123.84 | 2024-2025 | Prospera |
| Curonix LLC | $117.52 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Redhill Biopharma INC. | $104.74 | 2020-2022 | |
| Biodelivery Sciences International, INC. | $104.26 | 2019-2021 | |
| Pfizer INC. | $59.89 | 2019-2020 | |
| Abbott Laboratories | $58.91 | 2021-2024 | Proclaim |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Cable listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.